SUDEEP PHARMA LIMITED Share Price
SUDEEP PHARMA LIMITED Share Price Today
As of 5 Jul 2026, SUDEEP PHARMA LIMITED share price is ₹868.05. The stock opened at ₹868.00, compared to its previous close of ₹857.20. During today's trading session, SUDEEP PHARMA LIMITED share price moved in the range of ₹846.00 to ₹887.00, with an average price of ₹866.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹524.05 and a high of ₹887.00. On the performance front, SUDEEP PHARMA LIMITED share price has increased by 45.45% over the last six months and is up 12.13% on a year-on-year basis.
SUDEEP PHARMA LIMITED Returns Calculator
SUDEEP PHARMA LIMITED Shareholder Returns
SUDEEP PHARMA LIMITED Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
SUDEEP PHARMA LIMITED Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹502.00 | ₹459.28 | ₹428.74 | ₹343.01 |
| Other Income | ₹9.33 | ₹6.10 | ₹9.52 | ₹7.39 |
| Total Revenue | ₹511.33 | ₹465.38 | ₹438.26 | ₹350.40 |
| Total Expenses | ₹328.48 | ₹290.56 | ₹352.28 | ₹281.80 |
| Profit Before Tax | ₹182.85 | ₹174.82 | ₹85.98 | ₹68.60 |
| Tax | ₹44.15 | ₹41.63 | ₹23.66 | ₹18.44 |
| Profit After Tax | ₹138.69 | ₹133.19 | ₹62.32 | ₹50.17 |
| EPS - Basic | ₹12.78 | ₹12.28 | ₹5.74 | ₹356.01 |
| EPS - Diluted | ₹12.78 | ₹12.28 | ₹5.74 | ₹356.01 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹182.85 | ₹174.82 | ₹85.98 | ₹68.60 |
| Income before WC changes | ₹198.30 | ₹188.28 | ₹103.89 | ₹73.62 |
| Change in Assets | -₹112.50 | -₹44.91 | -₹45.64 | -₹87.50 |
| Change in Liabilities | ₹3.48 | -₹32.94 | ₹12.57 | ₹28.47 |
| Change in WC | -₹109.02 | -₹77.85 | -₹33.07 | -₹59.02 |
| Cash flow from Operations | ₹48.73 | ₹65.69 | ₹48.40 | -₹2.98 |
| Cash flow from Investing | -₹78.76 | -₹49.28 | -₹50.02 | -₹38.42 |
| Cash flow from Financing | ₹52.70 | -₹12.74 | -₹9.78 | ₹50.92 |
| Total Cash Flow | ₹22.67 | ₹3.67 | -₹11.40 | ₹9.52 |
| Cash (Start of the year) | ₹13.98 | ₹10.30 | ₹21.47 | ₹11.96 |
| Cash (End of the year) | ₹36.81 | ₹13.98 | ₹10.30 | ₹21.47 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹293.05 | ₹238.50 | ₹190.10 | ₹147.20 |
| Current Assets | ₹424.12 | ₹275.37 | ₹230.02 | ₹196.61 |
| Total Assets | ₹717.17 | ₹513.87 | ₹420.11 | ₹343.80 |
| Current Liabilities | ₹174.76 | ₹137.22 | ₹170.83 | ₹146.98 |
| Net Current Asset | ₹249.36 | ₹138.14 | ₹59.19 | ₹49.63 |
| Non-Current Liabilities | ₹49.32 | ₹20.61 | ₹26.00 | ₹33.48 |
| Equity Capital | ₹493.09 | ₹356.03 | ₹223.29 | ₹163.34 |
| Total Equity & Liabilities | ₹717.17 | ₹513.87 | ₹420.11 | ₹343.80 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹356.73 | ₹343.76 | ₹404.00 | ₹344.95 |
| Other Income | ₹8.38 | ₹8.20 | ₹11.18 | ₹8.08 |
| Total Revenue | ₹365.11 | ₹351.96 | ₹415.17 | ₹353.02 |
| Total Expenses | ₹235.70 | ₹219.65 | ₹324.40 | ₹282.62 |
| Profit Before Tax | ₹129.41 | ₹132.31 | ₹90.77 | ₹70.40 |
| Tax | ₹33.66 | ₹34.23 | ₹23.60 | ₹18.10 |
| Profit After Tax | ₹95.75 | ₹98.08 | ₹67.17 | ₹52.31 |
| EPS - Basic | ₹8.82 | ₹9.04 | ₹476.69 | ₹371.20 |
| EPS - Diluted | ₹8.82 | ₹9.04 | ₹476.69 | ₹371.20 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹129.41 | ₹132.31 | ₹90.77 | ₹70.40 |
| Income before WC changes | ₹138.37 | ₹140.70 | ₹103.31 | ₹75.62 |
| Change in Assets | -₹44.10 | ₹6.91 | -₹54.18 | -₹88.29 |
| Change in Liabilities | -₹5.44 | -₹52.33 | ₹14.97 | ₹24.41 |
| Change in WC | -₹49.54 | -₹45.42 | -₹39.22 | -₹63.89 |
| Cash flow from Operations | ₹59.15 | ₹59.05 | ₹42.31 | -₹5.33 |
| Cash flow from Investing | -₹91.59 | -₹40.67 | -₹40.71 | -₹27.97 |
| Cash flow from Financing | ₹54.20 | -₹16.14 | -₹10.11 | ₹39.98 |
| Total Cash Flow | ₹21.75 | ₹2.24 | -₹8.52 | ₹6.68 |
| Cash (Start of the year) | ₹8.59 | ₹6.35 | ₹14.87 | ₹8.19 |
| Cash (End of the year) | ₹30.35 | ₹8.59 | ₹6.35 | ₹14.87 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹291.08 | ₹219.85 | ₹180.17 | ₹141.34 |
| Current Assets | ₹313.02 | ₹230.75 | ₹235.85 | ₹191.83 |
| Total Assets | ₹604.10 | ₹450.60 | ₹416.03 | ₹333.17 |
| Current Liabilities | ₹130.82 | ₹104.51 | ₹163.71 | ₹142.07 |
| Net Current Asset | ₹182.20 | ₹126.24 | ₹72.15 | ₹49.76 |
| Non-Current Liabilities | ₹43.16 | ₹11.49 | ₹15.44 | ₹22.86 |
| Equity Capital | ₹430.12 | ₹334.60 | ₹236.88 | ₹168.24 |
| Total Equity & Liabilities | ₹604.10 | ₹450.60 | ₹416.03 | ₹333.17 |
About SUDEEP PHARMA LIMITED
Sudeep Pharma Private Limited is an India-based manufacturing pharmaceutical and nutraceutical products company. The Company is engaged in business of manufacturing and selling pharmaceutical and food, nutrition and specialty ingredients and intermediaries, used by pharmaceutical, food and nutrition industries globally. The Company a wide range of products, including mineral salts such as calcium salts, zinc salts, iron salts, potassium salts, magnesium salts, sodium salts, simethicone salts and copper salts. It offers products to a wide range of markets, which includes pharmaceuticals, dietary health, infant nutrition, beverage, dairy products, bakery products, confectionery, and staple food markets. Its subsidiaries include Sudeep Nutrition Private Limited, Sudeep Pharma USA Inc., Sudeep Pharma B.V., and Sudeep Advanced Materials Private Limited.
SUDEEP PHARMA LIMITED Financial Highlights
- Revenue: SUDEEP PHARMA LIMITED reported revenue of ₹670.85 crore in FY26 vs ₹511.33 crore in FY25. It showed an increase of 31.20% on a yearly basis.
- Operating Profit: SUDEEP PHARMA LIMITED reported an operating profit of ₹228.07 crore in FY26 vs ₹182.85 crore in FY25. It showed an increase of 24.73% on a year-on-year basis.
- Net Profit: SUDEEP PHARMA LIMITED reported a net profit of ₹174.28 crore in FY26 vs ₹138.73 crore in FY25. It showed an increase of 25.63% on a yearly basis.
SUDEEP PHARMA LIMITED Quarterly Result Highlights
- SUDEEP PHARMA LIMITED reported revenue of ₹188.76 crore in Mar 2026, compared with ₹179.18 crore in Dec 2025, representing an increase of 5.35% on a quarter-on-quarter (QoQ) basis.
- SUDEEP PHARMA LIMITED reported an operating profit of ₹62.69 crore in Mar 2026, compared with ₹61.78 crore in Dec 2025, representing an increase of 1.47% on a quarter-on-quarter (QoQ) basis.
- SUDEEP PHARMA LIMITED reported a profit of ₹48.54 crore in Mar 2026, compared with ₹47.70 crore in Dec 2025, reflecting an increase of 1.76% on a QoQ basis.
- The earnings per share (EPS) of SUDEEP PHARMA LIMITED stood at ₹12.78 during Mar 2026.
Similar Stocks
FAQs on SUDEEP PHARMA LIMITED Share Price
What is SUDEEP PHARMA LIMITED share price today?
SUDEEP PHARMA LIMITED share price is ₹868.05 as on 03 Jul, 2026, 15:58 IST.
How has the SUDEEP PHARMA LIMITED share price performed in the past?
In the last 1 year, SUDEEP PHARMA LIMITED delivered a return of 12.13%. The SUDEEP PHARMA LIMITED share price hit a high of ₹887.00 and low of ₹524.05.
How much is the Mutual Fund shareholding in SUDEEP PHARMA LIMITED shares?
The Mutual Fund Shareholding in SUDEEP PHARMA LIMITED was 6.19% at the end of Mar 2026.
What is the the 52-week high and low of SUDEEP PHARMA LIMITED shares ?
The 52-week high and low of SUDEEP PHARMA LIMITED share is ₹887.00 and ₹524.05 as of 03 Jul, 2026.
What is the market cap of SUDEEP PHARMA LIMITED?
The market capitalisation of SUDEEP PHARMA LIMITED is ₹9,674.05 Crores as on 03 Jul, 2026.
What are the stock symbols of SUDEEP PHARMA LIMITED?
The stock symbol of SUDEEP PHARMA LIMITED is SUDEEPPHRM on the NSE, 544619 on the BSE, and the ISIN is INE0QPI01025.
What was yesterday's closing price of SUDEEP PHARMA LIMITED shares ?
SUDEEP PHARMA LIMITED shares closed yesterday at ₹857.20 on NSE & ₹856.50 on BSE
How to buy SUDEEP PHARMA LIMITED shares?
To buy SUDEEP PHARMA LIMITED shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy SUDEEP PHARMA LIMITED shares on Holidays?
No, shares of SUDEEP PHARMA LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell SUDEEP PHARMA LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of SUDEEP PHARMA LIMITED?
The PE and PB ratio of SUDEEP PHARMA LIMITED is 55.51 and 10.95 respectively, as on 03 Jul, 2026, 15:58 IST.